These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3574096)

  • 1. [Push of inotropic drugs in the treatment of refractory chronic cardiac insufficiency].
    Martínez Martínez JA; Salvati A; Suárez LD
    Medicina (B Aires); 1986; 46(3):363-4. PubMed ID: 3574096
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments?].
    Sabbadini G; Ciaccheri M; Castelli G; Sinagra G; Di Lenarda A
    Ital Heart J Suppl; 2002 Aug; 3(8):804-11. PubMed ID: 12407835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New inotropic drugs in chronic cardiac insufficiency: progress or wrong track].
    Asseman P; Pruvost P; Lesenne M; Adnet P; Leroy F; Vigne JM; Delvallez L; Lacroix D; Thery C
    Ann Cardiol Angeiol (Paris); 1988 Mar; 37(3):153-61. PubMed ID: 3284451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?
    Chatterjee K; Wolfe CL; DeMarco T
    Cardiol Clin; 1994 Feb; 12(1):63-72. PubMed ID: 8181026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilators and inotropic agents in the treatment of congestive heart failure.
    Francis GS
    Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of inotropic agents in the treatment of cardiac insufficiency].
    Coma Canella I; López-Sendón J
    Rev Esp Cardiol; 1984; 37(3):186-95. PubMed ID: 6150525
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination of different inotropic agents in the treatment of chronic refractory cardiac insufficiency].
    Martínez Martínez A; Salvati A; Suárez LD
    Medicina (B Aires); 1987; 47(6):688-90. PubMed ID: 3505000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of resistant cardiac failure; vasodilators and new inotropic drugs].
    Herziano H; Gil I; Almog C
    Harefuah; 1980 Jun; 98(11-12):517-8. PubMed ID: 7203196
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inotropic agents].
    Yasumura Y
    Nihon Rinsho; 2006 May; 64(5):927-33. PubMed ID: 16689376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential therapy of chronic heart failure].
    Riegger AJ
    Internist (Berl); 1993 Oct; 34(10):939-43. PubMed ID: 8225843
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vasodilators in cardiac insufficiency].
    Bernardi LF; de Nononay NC
    Arq Bras Cardiol; 1980 Jan; 34(1):53-62. PubMed ID: 7406738
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phytogenic drugs in heart diseases exemplified by Crataegus].
    Loew D
    Wien Med Wochenschr; 1999; 149(8-10):226-8. PubMed ID: 10483686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inotropic agents in advanced and refractory heart failure].
    Mangiavacchi M; Gronda E
    Ital Heart J Suppl; 2003 Jan; 4(1):3-7. PubMed ID: 12690928
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic management of heart failure: positive inotropic agents.
    Cross JA
    Crit Care Nurs Clin North Am; 1993 Dec; 5(4):589-97. PubMed ID: 8297549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of heart failure. II. Therapy of chronic heart failure].
    Schwinger RH; Erdmann E
    Fortschr Med; 1997 Jun; 115(16):36-8, 41-5. PubMed ID: 9280747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of congestive heart failure: is the role of positive inotropic therapy fading?
    Futterman LG; Lemberg L
    Am J Crit Care; 1996 Nov; 5(6):455-60. PubMed ID: 8922162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New inotropic agents in the treatment of congestive heart failure].
    Hutton I; McKillop J; Clark R; Martin W; Tweddel A
    Ter Arkh; 1982; 54(11):98-101. PubMed ID: 7157176
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of refractory heart failure in the advanced phase of congestive myocardiopathy: new positive inotropic and vasodilator drugs].
    Permutti B; Maragno B; Stritoni P; Schivazappa L; Locatelli C
    Boll Soc Ital Cardiol; 1981; 26(1):59-65. PubMed ID: 7340860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.